非臨床試験

ソタテルセプトアナログの投与により、肺血管リモデリングの進展抑制及び改善が認められました（ラット）。

Yung LM et al. Sci Transl Med. 2020; 12（543）: eaaz5660.
Used with permission of American Association for the Advancement of Science,
from Yung LM et al. Sci Transl Med. 2020; 12(543): eaaz5660. , permission conveyed through Copyright Clearance Center, Inc.
Readers may view, browse, and/or download material for temporary copying purposes only, provided these uses are for noncommercial personal purposes. Except as provided by law, this material may not be further reproduced, distributed, transmitted, modified, adapted, performed, displayed, published, or sold in whole or in part, without prior written permission from the publisher.
COI：Acceleron Pharma（現MSD）より研究助成を受けている。著者にMSD及びAcceleron Pharma（現MSD）の社員やコンサルタントを含む。

社内資料：In vivoでの効力を裏付ける試験